Navigation Links
The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
Date:8/19/2007

membership agreements, customized IT systems, and an integrated tissue bank. For more information, please visit http://www.themmrc.org.

About Proteolix

Proteolix, Inc. is a biopharmaceutical company dedicated to discovering, developing and marketing pharmaceutical products that target certain cancers and immunological conditions by inhibiting the proteasome and thereby disrupting protein turnover in cells. In addition to its lead product candidate, carfilzomib (PR-171), which is delivered intravenously and is currently in multiple clinical trials to evaluate its safety and efficacy in different types of cancer, Proteolix is developing next generation proteasome inhibitors, including an oral proteasome inhibitor and a selective immunoproteasome inhibitor, to expand the therapeutic potential of this new target class. Proteolix is headquartered in South San Francisco. For more information, please visit the Company's website at http://www.proteolix.com.

MMRC Contact: Anne Quinn Young, Program Director, 203-652-0212

Proteolix Contact: Stephen R. Brady, Executive Director of Business & Legal Affairs, 650-615-7521


'/>"/>
SOURCE Proteolix

Copyright©2007 PR Newswire.

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
2. Velcade (Bortezomib) for Injection Based Therapies Produced Complete Remission Rates as High as 54 Percent in Patients With Previously Treated Multiple Myeloma
3. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
4. Gentiums Defibrotide Seen as Active in Multiple Myeloma
5. ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical Model
6. New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes
7. CytRx Announces Clinical Results from Its Rising Multiple Dose Trial with Arimoclomol for ALS
8. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
9. Velcade (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop
10. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
11. Orchestra Therapeutics Announces New Phase II Clinical Data on NeuroVax Demonstrating Marked Expansion of Regulatory T Cell Populations in Patients With Multiple Sclerosis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... According to Millennium Research ...ology market intelligence, the nearly $3 billion U... to see rapid growth over the next five years desp...s for Trauma Devices 2010 report finds that thi...five years, with competitors introducing specializ...
(Date:11/25/2009)... and JOHANNESBURG, November 25 ,iTh...iscovery announced today,that they have signed a c...anies, services. , Pyxis,s world class co...,will be coupled with iThemba,s service division t...t to projects identified through Pyxis,internatio...
(Date:11/24/2009)...wswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELG...r aortic disorders, announced today that it has fi...gs in, the patent infringement lawsuit brought aga...was filed in the United States District Court in I...d that the stay remain in effect while the United ...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Advanced Bag Design for Cryopreservation 3A The New CryoMACS 28R 29 Freezing Bag 51442 1Advanced Bag Design for Cryopreservation 3A The New CryoMACS 28R 29 Freezing Bag 51442 2RecoverCare and MedaSTAT USA to Merge Creating Leading Provider of Wound Care and Bariatric Treatment Solutions for Acute and Post Acute Care Markets 51440 1RecoverCare and MedaSTAT USA to Merge Creating Leading Provider of Wound Care and Bariatric Treatment Solutions for Acute and Post Acute Care Markets 51440 2RecoverCare and MedaSTAT USA to Merge Creating Leading Provider of Wound Care and Bariatric Treatment Solutions for Acute and Post Acute Care Markets 51440 3Gentiva 28R 29 Health Services Schedules Second Quarter Earnings Call and Web Cast for Thursday July 30 2009 51438 1Gentiva 28R 29 Health Services Schedules Second Quarter Earnings Call and Web Cast for Thursday July 30 2009 51438 2Gentiva 28R 29 Health Services Schedules Second Quarter Earnings Call and Web Cast for Thursday July 30 2009 51438 3Gentiva 28R 29 Health Services Schedules Second Quarter Earnings Call and Web Cast for Thursday July 30 2009 51438 4
... - ThromboGenics, Lead Product to be Studied in ...and Europe , ThromboGenics NV (Euronext Brusse...ative treatments for eye disease, vascular disease...he Phase III clinical program of,microplasmin for ...ase, the,final step in the clinical development of...
...idate Novel Gene Expression Biomarkers Involved in...tform , , FREMONT, Calif., Jan. 8 WaferGen Biosy...developer of state-of-the-art gene expression, gen...ms, today announced the signing of a research coll...rn Medical Center for the SmartChip(TM) Real-Time...
Other Medicine Technology:ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease 2ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease 3ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 2WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 3WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 5
(Date:11/27/2009)... Multi-purpose bilingual coloring...d for use by the business community to educate - i...ubjects from Safety issues to Dinosuars to ABC,S a... Saint Louis, MO (PRWEB) November 27, 2009 -- T...nics or toys to keep them busy any hour of the day...
(Date:11/26/2009)..., NEW YORK, Nov. 27 With cold an...r to employ good practices to control the spread o...be proactive not only to keep ourselves healthy, b...aid Eileen Finerty, RN, MS, CIC (certified in infe...trol and occupational health at Hospital for Speci...
(Date:11/26/2009)...pper sequestering drug tetrathiomolybdate (TM) has...tment of Wilson disease, a disease caused by an ov...That much is known. Very little, however, is known..., A new study led by Northwestern University res...three-dimensional structure of TM bound to copper-...
(Date:11/26/2009)... No more letters from the North P...alized text messages from Santa , ... increase operational efficiencies at the North Po...p keep children all over the globe informed of his...n Santa’s research department have identifie...
(Date:11/26/2009)... Benton Communications announces ...wth system for retailers struggling to make an eco... November 26, 2009 -- Flu fears is the type of cha... emergency room, according to Dr. David Benton, bu...sed business growth system – The Rfactor In...
Breaking Medicine News(10 mins):Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Pharmacist Injects Cure for Ailing Businesses 2
...w.SheKnows.com ), one of the fastest growing onlin...isition of PregnancyandBaby.com,( http://www.Pregn...omen from,preconception through pregnancy., Pregn...collection of articles, interactive features and a...
...ement by AIDS Service Center NYC of Safer Sex in t...EN:, Thursday, June 19, 2008, 7:30pm-10:00pm, VI...ravo "Project,Runway" stars Jack Mackenroth and Ke...kenroth and Christiana, Playboy Playmates, the,cas...
...ion (HCSC),which operates the Blue Cross and Blue ... Texas, has been declared by DiversityInc as one o... fourth year in a row.,Moreover, HCSC is listed as...for its CEO commitment, corporate,and organization...
...lie),Goldstein was honored with the first Californ...n Award in a presentation at his home in Los Angel... Saturday, May 10. Dr.,Goldstein passed away the f...ntly established by the,Foundation to recognize Ca...
...ulti-year expansion to better ad...y 14 The Kresge Foundation,s first,quarter awards...to,grantmaking as well as its early exploration of...ed 54 awards of $42,694,500 in,six fields of inter...
... road, JOHNS CREEK, Ga., May 14 Saia, Inc. (Nasd...nique yearlong breast cancer,awareness campaign, "...", Saia, a leading less-than-truckload carrier, h... As the "pink truck",travels throughout the United...
Other Medicine News:Health News:SheKnows Acquires PregnancyandBaby - Online Community From Preconception Through Birth 2Health News:Hosting Summer's Sexiest Benefit, AIDS Service Center NYC Teams With Playboy Playmates, 'Project Runway' Stars, 'Naked Boys Singing' 2Health News:Health Care Service Corporation Ranked in Top 10 for Executive Women and for People With Disabilities 2Health News:The California Dental Association Foundation Presents Inaugural Humanitarian Award to USC Mobile Dental Clinics Champion Charles M. Goldstein, DDS, MPH 2Health News:The California Dental Association Foundation Presents Inaugural Humanitarian Award to USC Mobile Dental Clinics Champion Charles M. Goldstein, DDS, MPH 3Health News:Kresge Foundation Employs New Funding Methods in its First Quarter Grant Awards of Nearly $43 Million 2Health News:Kresge Foundation Employs New Funding Methods in its First Quarter Grant Awards of Nearly $43 Million 3Health News:Kresge Foundation Employs New Funding Methods in its First Quarter Grant Awards of Nearly $43 Million 4Health News:Kresge Foundation Employs New Funding Methods in its First Quarter Grant Awards of Nearly $43 Million 5Health News:Kresge Foundation Employs New Funding Methods in its First Quarter Grant Awards of Nearly $43 Million 6Health News:Kresge Foundation Employs New Funding Methods in its First Quarter Grant Awards of Nearly $43 Million 7Health News:Kresge Foundation Employs New Funding Methods in its First Quarter Grant Awards of Nearly $43 Million 8Health News:Saia Partners with Susan G. Komen for the Cure 2Health News:Saia Partners with Susan G. Komen for the Cure 3
...t) microfiltration units provide a reproducible me...on onto nitrocellulose or Zeta-Probe membrane. Man...ing interchangeable templates to form the 96-well ...F apparatus. Each is available as a complete, inde...
...t) microfiltration units provide a reproducible me...on onto nitrocellulose or Zeta-Probe membrane. Man...ing interchangeable templates to form the 96-well ...F apparatus. Each is available as a complete, inde...
Slot Blotting Apparatus
...igned for a variety of applications that employ co...ranes. The tray has the same exterior dimensions a...ious automated liquid handling instruments and acc...hout trimming., With a snug fitting lid to mi...
Medicine Products: